cannabis indica

Índice completo — página 72 de 77

Estudos 7.101 a 7.200 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2005 a 2003. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 7.101 a 7.200

  1. 2005

    Pain measurements and side effect profile of the novel cannabinoid ajulemic acid

    FavorávelEnsaio Clínico Duplo-CegoDorDor — CrônicaDor — Neuropatia PeriféricaCanabinoide Sintético (não especificado)
  2. 2005

    Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals

    FavorávelMetanáliseDorInflamaçãoDor — AgudaPalmitoiletanolamida (PEA)
  3. 2005

    Paroxysmal Atrial Fibrillation After Recreational Marijuana Smoking: Another "Holiday Heart"?

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)Fibrilação Atrial
  4. 2005

    Prevention Of Alzheimer's Disease Pathology By Cannabinoids: Neuroprotection Mediated By Blockade Of Microglial Activation

    FavorávelEstudo em AnimaisDoença de AlzheimerCanabinoides Sintéticos WIN-xCanabinoides Sintéticos JWH-x+1
  5. 2005

    Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

    FavorávelEnsaio Clínico Duplo-CegoDorInsônia e Distúrbios do SonoEsclerose MúltiplaTetraidrocanabinol (THC)THC:CBD Farmacêutico+1
  6. 2005

    Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure

    InconclusivoEnsaio ClínicoTHC Farmacêutico
  7. 2005

    Sativex for the management of multiple sclerosis symptoms.

    FavorávelMetanáliseEsclerose MúltiplaTetraidrocanabinol (THC)THC:CBD Farmacêutico
  8. 2005

    Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus

    FavorávelEstudo Laboratorial2-Araquidonoilglicerol (2-AG)Monoacilglicerol Lipase (MAGL)
  9. 2005

    Survey of Australians using cannabis for medical purposes

    FavorávelMetanáliseDorDor — CrônicaDepressão+4
  10. 2005

    The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis.

    FavorávelEstudo em AnimaisPancreatiteAnandamida (AEA)Canabinoides Sintéticos AM-x
  11. 2005

    The cannabinoid system and its importance in the perinatal period

    FavorávelMetanáliseAlterações Cerebrais Neonatais
  12. 2005

    The effect of nabilone on neuropsychological functions related to driving ability: an extended case series

    FavorávelEnsaio Clínico Duplo-CegoEsclerose MúltiplaTHC Farmacêutico
  13. 2005

    The Efficacy and Tolerability of Long-Term Use of Dronabinol in Cancer-Related Anorexia: A Case Series

    FavorávelEnsaio ClínicoCâncerAnorexia (perda de apetite)THC Farmacêutico
  14. 2005

    The Endogenous Cannabinoid, Anandamide, Induces Cell Death In Colorectal Carcinoma Cells: A Possible Role For Cyclooxygenase 2

    FavorávelEstudo LaboratorialCâncerCâncer — CólonAnandamida (AEA)
  15. 2005

    The monoterpene terpinolene from the oil of Pinus mugo L. in concert with alpha-tocopherol and beta-carotene effectively prevents oxidation of LDL.

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)
  16. 2005

    The search for the palmitoylethanolamide receptor

    FavorávelMetanáliseDorInflamaçãoDor — CrônicaEndocanabinoide (não especificado)Palmitoiletanolamida (PEA)+1
  17. 2005

    Therapeutic opportunities through modulation of the endocannabinoid system

    InconclusivoMetanáliseDorInflamaçãoDor — Neuropatia PeriféricaAnandamida (AEA)Tetraidrocanabinol (THC)+10
  18. 2005

    Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta

    InconclusivoEstudo em AnimaisDoenças Cardiovasculares (DCV)Hipertensão ArterialAnandamida (AEA)N-Araquidonoil Dopamina (NADA)
  19. 2004

    [Experiences with dronabinol (delta-tetrahydrocannabinol) in oncological patients with anorexia-cachexia syndrome. Illustration of clinical problems and therapy based on 2 case reports]

    FavorávelMetanáliseCaquexiaAnorexia NervosaTHC Farmacêutico
  20. 2004

    A case of cannabis-induced pancreatitis

    DesfavorávelMetanálisePancreatite
  21. 2004

    A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days

    InconclusivoEnsaio ClínicoCâncer
  22. 2004

    Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC

    DesfavorávelEstudo em AnimaisDorEfeitos Adversos da CannabisDor — AgudaTetraidrocanabinol (THC)
  23. 2004

    Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid.

    FavorávelEstudo em AnimaisEsclerose Lateral Amiotrófica (ELA)
  24. 2004

    An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis

    FavorávelEnsaio ClínicoDorEsclerose MúltiplaIncontinência UrináriaTetraidrocanabinol (THC)
  25. 2004

    Anandamide content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition.

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Hipertensão ArterialAnandamida (AEA)Canabinoides Sintéticos SR-x
  26. 2004

    Anticonvulsant activity and chemical composition of Artemisia dracunculus L. essential oil.

    FavorávelEstudo LaboratorialEpilepsiaEpilepsia — Lennox-Gastaut
  27. 2004

    Antitumor Effects Of Cannabidiol, A Nonpsychoactive Cannabinoid, On Human Glioma Cell Lines

    FavorávelEstudo em AnimaisCâncerCâncer — Cérebro
  28. 2004

    Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1.

    FavorávelEstudo LaboratorialCâncerCâncer — Colo do ÚteroOutros Compostos Relacionados
  29. 2004

    Are oral cannabinoids safe and effective in refractory neuropathic pain?

    InconclusivoEnsaio Clínico Duplo-CegoDorAnsiedadeDor — Crônica+2
  30. 2004

    Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes

    InconclusivoMetanáliseAnorexia (perda de apetite)Anorexia Nervosa
  31. 2004

    Cannabidiol Prevents Infarction via the non-CB1 Cannabinoid Receptor Mechanism

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)InfartoTetraidrocanabinol (THC)
  32. 2004

    Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism.

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Tetraidrocanabinol (THC)Canabinoides Sintéticos SR-x
  33. 2004

    Cannabinoid Agonists in the Treatment of Blepharospasm--A Case Report Study

    FavorávelMetanáliseDistoniaCoreiaBlefaroespasmoTetraidrocanabinol (THC)THC Farmacêutico
  34. 2004

    Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse

    DesfavorávelMetanáliseNáusea e VômitoSíndrome da Hiperêmese Canabinoide
  35. 2004

    Cannabinoids and gene expression during brain development

    InconclusivoMetanáliseGestaçãoAlterações Cerebrais Neonatais
  36. 2004

    Cannabinoids and glaucoma.

    FavorávelMetanáliseGlaucomaTetraidrocanabinol (THC)Canabinoides Sintéticos HU-x
  37. 2004

    Cannabinoids as neuroprotective agents in traumatic brain injury

    FavorávelMetanáliseTraumatismo CranioencefálicoEndocanabinoide (não especificado)Canabinoide Sintético (não especificado)
  38. 2004

    Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect.

    FavorávelEstudo em AnimaisDorDiabetesDor — Neuropatia DiabéticaCanabinoides Sintéticos WIN-x
  39. 2004

    Cannabinoids Inhibit The Vascular Endothelial Growth Factor Pathway In Gliomas

    FavorávelEnsaio ClínicoCâncerCâncer — CérebroAnandamida (AEA)Tetraidrocanabinol (THC)+3
  40. 2004

    Cannabinoids Prevent the Acute Hyperthermia and Partially Protect Against the 5-HT Depleting Effects of MDMA ("Ecstasy") in Rats

    FavorávelEstudo em AnimaisAnsiedadeEpilepsiaEfeitos Adversos do MDMACanabinoides Sintéticos SR-xCanabinoides Sintéticos CP-x+1
  41. 2004

    Cannabis As A Substitute For Alcohol: A Harm-reduction Approach

    FavorávelMetanáliseDependência QuímicaDependência — Álcool
  42. 2004

    Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study

    DesfavorávelEnsaio Clínico Duplo-CegoDoença de ParkinsonTetraidrocanabinol (THC)
  43. 2004

    Cannabis improves night vision: a case study of dark adaptometry and scotopic sensitivity in kif smokers of the Rif mountains of northern Morocco.

    FavorávelMetanáliseCegueira Noturna
  44. 2004

    Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms.

    FavorávelMetanálisePsicoseEsquizofreniaAnandamida (AEA)
  45. 2004

    Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA)

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Hipertensão ArterialN-Araquidonoil Dopamina (NADA)
  46. 2004

    Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors

    FavorávelEstudo LaboratorialTetraidrocanabinol (THC)Canabinoides Sintéticos WIN-x+4
  47. 2004

    Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice.

    InconclusivoEstudo em AnimaisAnsiedadeTranstornos de Comportamento
  48. 2004

    Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro

    FavorávelEstudo LaboratorialHerpesHerpes-ZósterSarcoma de Kaposi+1
  49. 2004

    Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans

    DesfavorávelEnsaio Clínico Duplo-CegoDorTHC Farmacêutico
  50. 2004

    Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo- controlled study on 160 patients

    FavorávelEnsaio Clínico Duplo-CegoEsclerose MúltiplaTetraidrocanabinol (THC)
  51. 2004

    Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

    FavorávelEnsaio Clínico Duplo-CegoEsclerose MúltiplaTHC Farmacêutico
  52. 2004

    Down-regulation of the AMPA glutamate receptor subunits GluR1 and GluR2/3 in the rat cerebellum following pre- and perinatal delta9-tetrahydrocannabinol exposure

    DesfavorávelEstudo em AnimaisGestaçãoAlterações Cerebrais Neonatais
  53. 2004

    Effect Of Low Doses Of Delta9-tetrahydrocannabinol And Cannabidiol On The Extinction Of Cocaine-induced And Amphetamine-induced Conditioned Place Preference Learning In Rats

    FavorávelEstudo em AnimaisDependência QuímicaDependência — CocaínaDependência — EstimulantesTetraidrocanabinol (THC)Canabinoides Sintéticos SR-x
  54. 2004

    Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDorDor — CrônicaLesões do Plexo BraquialTHC FarmacêuticoTHC:CBD Farmacêutico
  55. 2004

    Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study

    InconclusivoEnsaio Clínico Duplo-CegoEsclerose MúltiplaTetraidrocanabinol (THC)
  56. 2004

    Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis

    FavorávelEstudo em Animais2-Araquidonoilglicerol (2-AG)Canabinoides Sintéticos AM-x+2
  57. 2004

    Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade.

    FavorávelEstudo em AnimaisDependência QuímicaDependência — EstimulantesCanabinoides Sintéticos SR-x
  58. 2004

    Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension.

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Hipertensão ArterialAnandamida (AEA)Canabinoide Sintético (não especificado)+4
  59. 2004

    Endocannabinoids and exercise

    FavorávelMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  60. 2004

    Endocannabinoids and Their Implications for Epilepsy.

    FavorávelMetanáliseEpilepsiaAnandamida (AEA)Tetraidrocanabinol (THC)+3
  61. 2004

    Endogenous cannabinoids are candidates for lipid mediators of bone cement implantation syndrome

    DesfavorávelEnsaio ClínicoRedução de DanosAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  62. 2004

    First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol

    DesfavorávelEnsaio ClínicoPsicoseEsquizofrenia
  63. 2004

    Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol

    FavorávelEstudo LaboratorialDoenças de PeleCanabinol (CBN)Delta-8-THC
  64. 2004

    Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers

    FavorávelEnsaio Clínico Duplo-CegoDoença de Parkinson
  65. 2004

    In vitro/in vivo correlation studies for transdermal delta 8-THC development

    InconclusivoEstudo LaboratorialDelta-8-THC
  66. 2004

    Involvement of cannabinoid receptors in gut motility and visceral perception

    FavorávelMetanáliseSíndrome do Intestino IrritávelDII — Doença de CrohnRefluxo GastroesofágicoAnandamida (AEA)Tetraidrocanabinol (THC)+3
  67. 2004

    Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use

    DesfavorávelMetanáliseTentativa de Suicídio
  68. 2004

    Marijuana use and risk of oral squamous cell carcinoma

    InconclusivoMetanáliseCâncerCâncer — Escamoso de Cabeça e PescoçoCâncer — Boca
  69. 2004

    Marijuana withdrawal in humans: effects of oral THC or divalproex

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  70. 2004

    Neurocognitive Performance Of Methamphetamine Users Discordant For History Of Marijuana Exposure

    InconclusivoMetanáliseDependência QuímicaDependência — Estimulantes
  71. 2004

    Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease

    DesfavorávelEnsaio Clínico Duplo-CegoDoença de ParkinsonCanabinoides Sintéticos SR-x
  72. 2004

    Neuroprotective Effect Of Cannabidiol, A Non-psychoactive Component From Cannabis Sativa, On Beta-amyloid-induced Toxicity In PC12 Cells

    FavorávelEstudo LaboratorialEstresse OxidativoDoença de Alzheimer
  73. 2004

    Presynaptic cannabinoid CB1 receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats

    FavorávelEstudo em AnimaisSepseSíndrome do Choque TóxicoCanabinoides Sintéticos SR-x
  74. 2004

    Reductions in levels of bacterial superantigens/cannabinoids by plasma exchange in a patient with severe toxic shock syndrome

    InconclusivoMetanáliseInfecção por EstafilococosSepseSíndrome do Choque TóxicoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  75. 2004

    Role of the endocannabinoid system in Alzheimer's disease: new perspectives.

    FavorávelEstudo LaboratorialDoença de Alzheimer
  76. 2004

    Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisAnsiedadeDepressão+5
  77. 2004

    Survey Of Cannabis Use In Patients With Amyotrophic Lateral Sclerosis

    FavorávelMetanáliseEsclerose Lateral Amiotrófica (ELA)
  78. 2004

    Survey on cannabis use in Parkinson's disease: Subjective improvement of motor symptoms.

    FavorávelMetanáliseDoença de Parkinson
  79. 2004

    Synergistic interactions between cannabinoid and opioid analgesics

    FavorávelMetanáliseDorDependência QuímicaDor — CrônicaTetraidrocanabinol (THC)+2
  80. 2004

    Synthesis and antitumor activity of quinonoid derivatives of cannabinoids

    FavorávelEstudo LaboratorialCâncerEstresse OxidativoCanabinol (CBN)Delta-8-THC
  81. 2004

    The effect of cannabis on tremor in patients with multiple sclerosis

    InconclusivoEnsaio Clínico Duplo-CegoEsclerose Múltipla
  82. 2004

    The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats.

    FavorávelEstudo em AnimaisDorDor — Neuropatia DiabéticaCanabinoides Sintéticos WIN-x
  83. 2004

    The involvement of VEGF receptors and MAPK in the cannabinoid potentiation of Ca2+ flux into N18TG2 neuroblastoma cells

    InconclusivoEstudo LaboratorialCâncerCâncer — Neuroblastoma
  84. 2004

    The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis

    InconclusivoEnsaio Clínico Duplo-CegoPsicoseEsquizofreniaTHC Farmacêutico
  85. 2004

    Therapy for acute nonpurulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial.

    FavorávelEnsaio Clínico Duplo-CegoTosse
  86. 2004

    Transdermal Absorption of (-)-Linalool Induces Autonomic Deactivation but Has No Impact on Ratings of Well-Being in Humans

    FavorávelEnsaio Clínico Duplo-CegoDoenças Cardiovasculares (DCV)Hipertensão Arterial
  87. 2004

    Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.

    FavorávelEstudo em AnimaisDorDor — Polineuropatia InflamatóriaCanabinoides Sintéticos SR-x
  88. 2004

    Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)Hipertensão ArterialVirodamina (O-AEA)
  89. 2004

    Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss

    FavorávelEstudo em AnimaisObesidadeDiabetesSíndrome MetabólicaDelta-8-THC
  90. 2004

    Voluntary exercise augments acute effects of CB1-receptor inverse agonist on body weight loss in obese and lean mice

    FavorávelEstudo em AnimaisObesidadeCanabinoides Sintéticos AM-x
  91. 2003

    A Case of Cannabinoid Rotation in a Young Woman With Chronic Cystitis.

    FavorávelMetanáliseCistiteTetraidrocanabinol (THC)THC Farmacêutico
  92. 2003

    A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation.

    FavorávelEstudo LaboratorialHepatiteCanabinoide Sintético (não especificado)
  93. 2003

    A Phase I Trial of Perillyl Alcohol in Patients With Advanced Solid Tumors

    InconclusivoEnsaio ClínicoCâncer
  94. 2003

    A predominant role for inhibition of the adenylate cyclase/protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells

    InconclusivoEstudo LaboratorialCâncerCâncer — NeuroblastomaCanabinoides Sintéticos WIN-x
  95. 2003

    A Preliminary Controlled Study To Determine Whether Whole-plant Cannabis Extracts Can Improve Intractable Neurogenic Symptoms

    FavorávelEnsaio Clínico Duplo-CegoDorDor — CrônicaEsclerose Múltipla+2
  96. 2003

    An Endogenous Cannabinoid Tone Attenuates Cholera Toxin-Induced Fluid Accumulation in Mice

    InconclusivoEstudo em AnimaisDiarreiaCóleraAnandamida (AEA)Canabinoides Sintéticos CP-x
  97. 2003

    Analgesic Effect of the Synthetic Cannabinoid CT-3 on Chronic Neuropathic Pain: A Randomized Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDor — CrônicaDor — Neuropatia PeriféricaDelta-8-THC
  98. 2003

    Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial

    FavorávelEnsaio Clínico Duplo-CegoAsma
  99. 2003

    Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production.

    FavorávelEstudo LaboratorialCâncerCâncer — PróstataAnandamida (AEA)
  100. 2003

    Antileishmanial Activity of a Linalool-Rich Essential Oil from Croton cajucara.

    FavorávelEstudo LaboratorialLeishmaniose